Switch to:
GlaxoSmithKline PLC (NYSE:GSK)
Piotroski F-Score
7 (As of Today)

Good Sign:

Piotroski F-Score of 7 is 7, indicating very healthy situation.

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

GlaxoSmithKline PLC has an F-score of 7 indicating the company's financial situation is typical for a stable company.

GSK' s 10-Year Piotroski F-Score Range
Min: 3   Max: 8
Current: 7

3
8

During the past 13 years, the highest Piotroski F-Score of GlaxoSmithKline PLC was 8. The lowest was 3. And the median was 5.


Definition

How is the Piotroski F-Score calculated?

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

This Year (Jun14) TTM:Last Year (Jun13) TTM:
Net Income was 1560.38647343 + 4054.36573311 + 1118.9279732 + 1116.04095563 = $7,850 Mil.
Cash Flow from Operations was 3344.60547504 + 3602.96540362 + 1552.7638191 + 1307.16723549 = $9,808 Mil.
Revenue was 10483.0917874 + 11377.2652389 + 9402.01005025 + 9489.76109215 = $40,752 Mil.
Gross Profit was 7083.73590982 + 7215.815486 + 6482.4120603 + 6551.19453925 = $27,333 Mil.
Average Total Assets from the begining of this year (Jun13)
to the end of this year (Jun14) was
(63822.4582701 + 66199.6779388 + 69334.431631 + 66510.8877722 + 66296.9283276) / 5 = $66,433 Mil.
Total Assets was $66,297 Mil.
Long-Term Debt was $24,756 Mil.
Total Current Assets was $23,128 Mil.
Total Current Liabilities was $20,908 Mil.
Net Income was 1803.8585209 + 1380.19169329 + 1471.66921899 + 1585.73596358 = $6,241 Mil.

Revenue was 10493.5691318 + 10865.8146965 + 9909.64777948 + 10042.4886191 = $41,312 Mil.
Gross Profit was 7147.90996785 + 7653.35463259 + 6883.61408882 + 7050.07587253 = $28,735 Mil.
Average Total Assets from the begining of last year (Jun12)
to the end of last year (Jun13) was
(66235.5694228 + 65036.977492 + 66253.9936102 + 65684.532925 + 63822.4582701) / 5 = $65,407 Mil.
Total Assets was $63,822 Mil.
Long-Term Debt was $24,733 Mil.
Total Current Assets was $20,388 Mil.
Total Current Liabilities was $18,933 Mil.

Profitability

Q1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by average total assets throughout the year.

Score 1 if positive, 0 if negative.

GlaxoSmithKline PLC's current net income (ttm) was 7,850. ==> Positive ==> Score 1.

Q2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by average total assets throughout the year.

Score 1 if positive, 0 if negative.

GlaxoSmithKline PLC's current cash flow from operations (ttm) was 9,808. ==> Positive ==> Score 1.

Q3. Change in Return on Assets

Compare this year’s return on assets (1) to last year’s return on assets.

Score 1 if it’s higher, 0 if it’s lower.

ROA (This Year)=Net Income (TTM)/Average Total Assets from Jun13 to Jun14
=7849.72113537/66432.8767879
=0.11816019

ROA (Last Year)=Net Income (TTM)/Average Total Assets from Jun12 to Jun13
=6241.45539676/65406.706344
=0.09542531

GlaxoSmithKline PLC's return on assets of this year was 0.11816019. GlaxoSmithKline PLC's return on assets of last year was 0.09542531. ==> This year is higher. ==> Score 1.

Q4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA =< ROA.

GlaxoSmithKline PLC's current net income (ttm) was 7,850. GlaxoSmithKline PLC's current cash flow from operations (ttm) was 9,808. ==> 9,808 > 7,850 ==> CFROA > ROA ==> Score 1.

Funding

Q5. Change in Gearing or Leverage

Compare this year’s gearing (long-term debt divided by total assets) to last year’s gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun14)=Long-Term Debt/Total Assets
=24755.9726962/66296.9283276
=0.37341055

Gearing (Last Year: Jun13)=Long-Term Debt/Total Assets
=24732.9286798/63822.4582701
=0.38752705

GlaxoSmithKline PLC's gearing of this year was 0.37341055. GlaxoSmithKline PLC's gearing of last year was 0.38752705. ==> This year is lower or equal to last year. ==> Score 1.

Q6. Change in Working Capital (Liquidity)

Compare this year’s current ratio (current assets divided by current liabilities) to last year’s current ratio.

Score 1 if this year'’s current ratio is higher, 0 if it’s lower

Current Ratio (This Year: Jun14)=Total Current Assets/Total Current Liabilities
=23127.9863481/20907.8498294
=1.10618675

Current Ratio (Last Year: Jun13)=Total Current Assets/Total Current Liabilities
=20388.4673748/18933.23217
=1.07686143

GlaxoSmithKline PLC's current ratio of this year was 1.10618675. GlaxoSmithKline PLC's current ratio of last year was 1.07686143. ==> This year's current ratio is higher. ==> Score 1.

Q7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

GlaxoSmithKline PLC's number of shares in issue this year was 2437. GlaxoSmithKline PLC's number of shares in issue last year was 2459. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Q8. Change in Gross Margin

Compare this year’s gross margin (gross profit divided by sales) to last year’s.

Score 1 if this year’s gross margin is higher, 0 if it’s lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=27333.1579954/40752.1281687
=0.67071732

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=28734.9545618/41311.5202269
=0.69556759

GlaxoSmithKline PLC's gross margin of this year was 0.67071732. GlaxoSmithKline PLC's gross margin of last year was 0.69556759. ==> Last year's gross margin is higher ==> Score 0.

Q9. Change in asset turnover

Compare this year’s asset turnover (total sales for the year divided by average total assets throughout the year) to last year’s asset turnover ratio.

Score 1 if this year’s asset turnover ratio is higher, 0 if it’s lower

Asset Turnover (This Year)=Revenue (TTM)/Average Total Assets from Jun13 to Jun14
=40752.1281687/66432.8767879
=0.61343314

Asset Turnover (Last Year)=Revenue (TTM)/Average Total Assets from Jun12 to Jun13
=41311.5202269/65406.706344
=0.63160985

GlaxoSmithKline PLC's asset turnover of this year was 0.61343314. GlaxoSmithKline PLC's asset turnover of last year was 0.63160985. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score=Q1+Q2+Q3+Q4+Q5+Q6+Q7+Q8+Q9
=1+1+1+1+1+1+1+0+0
=7

Good or high score = 8 or 9

Bad or low score = 0 or 1

GlaxoSmithKline PLC has an F-score of 7 indicating the company's financial situation is typical for a stable company.


Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Related Terms

Net Income, Cash Flow from Operations, Revenue, Gross Profit, Total Assets, Long-Term Debt, Total Current Assets, Total Current Liabilities, Altman Z-Score, Beneish M-Score


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

GlaxoSmithKline PLC Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
Q1 1111111111
Q2 1111111111
Q3 0010101
Q4 1111101
Q5 0010100
Q6 0100001
Q7 1110111
Q8 0010000
Q9 0010001
F-score 4583637

GlaxoSmithKline PLC Quarterly Data

Mar12Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14
Q1 1111111111
Q2 1111111111
Q3 1110000111
Q4 1100111111
Q5 1110000011
Q6 0000101101
Q7 1111111101
Q8 1100000000
Q9 1100000000
F-score 8853545657
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK